Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
66,018,446
-
Share change
-
+314,246
-
Total reported value
-
$446,683,816
-
Put/Call ratio
-
0%
-
Price per share
-
$6.77
-
Number of holders
-
160
-
Value change
-
+$3,690,649
-
Number of buys
-
72
-
Number of sells
-
71
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2021
As of 31 Dec 2021,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,018,446 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, LSV ASSET MANAGEMENT, ROYCE & ASSOCIATES LP, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
160
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.